Kaya Holdings, Inc. (KAYS)
OTCMKTS · Delayed Price · Currency is USD
0.0431
+0.0071 (19.72%)
Jan 20, 2026, 9:30 AM EST
Kaya Holdings Market Cap
Kaya Holdings has a market cap or net worth of $29.59 million as of January 21, 2026. Its market cap has increased by 2,799.08% in one year.
Market Cap
29.59M
Enterprise Value
27.97M
Revenue
26.69K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since January 7, 2010, Kaya Holdings's market cap has increased from 10.13K to 29.59M, an increase of 292,100.27%. That is a compound annual growth rate of 64.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 29.59M | 9.00% |
| Dec 31, 2025 | 27.14M | 2,231.67% |
| Dec 31, 2024 | 1.16M | 24.70% |
| Dec 29, 2023 | 933.48K | -33.27% |
| Dec 30, 2022 | 1.40M | -28.34% |
| Dec 31, 2021 | 1.95M | -64.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |